| abstract |
A single pharmaceutical dosage composition or dosage form comprising crystalline 3- (4-amino-1-oxo-1,3-dihydroisoindol-2-yl) -piperidin-2,6-dione and optionally one or more excipients or diluents, said 3- (4-amino-1-oxo-1,3-dihydroisoindol-2-yl) -piperidine-2,6-dione crystalline having an X-ray powder diffraction pattern comprising peaks at 8, 14.5 ; 16, 17.5, 20.5; 24 and 26 degrees 2θ. |